Lobelia
A traditional herb whose alkaloid lobeline resembles nicotine and was long promoted for quitting smoking. Cochrane found no evidence that it works, and the plant is genuinely toxic at higher doses.
Evidence last reviewed: August 2026
What the science says
- No evidence for smoking cessation Moderate evidence
A Cochrane review of lobeline for smoking cessation found no trials showing a benefit on long-term abstinence, with the available studies too small and too short to detect an effect. The conclusion was that lobeline cannot be recommended.
- Pharmacological rationale without clinical support Limited evidence
Lobeline interacts with nicotinic receptors and vesicular monoamine transport in laboratory studies, which is the basis of interest in it for stimulant and nicotine dependence. Reviews of Lobelia species note that this preclinical activity has never translated into clinical benefit.
Dosage & safety
Scientific references
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Stress & mood
- Ashwagandha Moderate evidence
- L-Methylfolate Limited evidence
- 5-HTP Limited evidence
- L-Ornithine Limited evidence
- SAM-e Moderate evidence
- Rhodiola Rosea Limited evidence